Welcome to LookChem.com Sign In|Join Free

CAS

  • or

160446-22-0

Post Buying Request

160446-22-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

160446-22-0 Usage

General Description

Methyl 4-(methanesulfonylmethyl)benzoate is a chemical compound with the molecular formula C10H12O4S. It is a derivative of benzoic acid and is commonly used as a flavoring agent and fragrance in various cosmetic and personal care products. METHYL 4-(METHANESULFONYLMETHYL)BENZOATE is also known for its anti-inflammatory and antifungal properties, making it a popular ingredient in topical pharmaceutical formulations. Methyl 4-(methanesulfonylmethyl)benzoate is a white crystalline powder with a sweet, fruity odor and is soluble in alcohol and propylene glycol. It is important to handle this chemical with care and follow safety guidelines to prevent potential health hazards.

Check Digit Verification of cas no

The CAS Registry Mumber 160446-22-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,6,0,4,4 and 6 respectively; the second part has 2 digits, 2 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 160446-22:
(8*1)+(7*6)+(6*0)+(5*4)+(4*4)+(3*6)+(2*2)+(1*2)=110
110 % 10 = 0
So 160446-22-0 is a valid CAS Registry Number.
InChI:InChI=1/C10H12O4S/c1-14-10(11)9-5-3-8(4-6-9)7-15(2,12)13/h3-6H,7H2,1-2H3

160446-22-0 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (L05657)  Methyl 4-(methylsulfonylmethyl)benzoate, 98%   

  • 160446-22-0

  • 2g

  • 840.0CNY

  • Detail
  • Alfa Aesar

  • (L05657)  Methyl 4-(methylsulfonylmethyl)benzoate, 98%   

  • 160446-22-0

  • 10g

  • 3241.0CNY

  • Detail

160446-22-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name methyl 4-(methylsulfonylmethyl)benzoate

1.2 Other means of identification

Product number -
Other names Methyl 4-(methylsulfonylmethyl)benzoate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:160446-22-0 SDS

160446-22-0Relevant articles and documents

SUBSTITUTED PYRIDINES AS INHIBITORS OF DNMT1

-

, (2018/01/20)

The invention is directed to substituted pyridine derivatives. Specifically, the invention is directed to compounds according to Formula (Iar): (Iar) wherein Yar, X1ar, X2ar, R1ar, R2ar, R3ar, R4ar and R5ar are as defined herein; or a pharmaceutically acceptable salt or prodrug thereof. The compounds of the invention are selective inhibitors of DNMT1 and can be useful in the treatment of cancer, pre-cancerous syndromes, beta hemoglobinopathy disorders, sickle cell disease, sickle cell anemia, and beta thalassemia, and diseases associated with DNMT1 inhibition. Accordingly, the invention is further directed to pharmaceutical compositions comprising a compound of the invention. The invention is still further directed to methods of inhibiting DNMT1 activity and treatment of disorders associated therewith using a compound of the invention or a pharmaceutical composition comprising a compound of the invention.

Reparametrization and/or determination of hammett, inductive, mesomeric and aise substituent constants for five substituents: N+(CH 3)3, CH2N+(CH3) 3, CH2Py+, CH2SO2CH 3 and PO(OCH3)2

Picha, Jan,Cibulka, Radek,Liska, Frantisek,Parik, Patrik,Pytela, Oldrich

, p. 2239 - 2252 (2007/10/03)

Ten meta- and para-substituted benzoic acids with substituants N +(CH3)3, CH2N+(CH 3)3, CH2Py+, CH2SO 2CH3 and PO(OCH3)2 were synthesized. Dissociation constants of these acids were determined in five solvents (water, ethanol, methanol, N,N-dimethylformamide, dimethyl sulfoxide) at 25°C. Dissociation constants of benzoic acid derivatives with other substituents H, CH3, NHCOCH3, OCH3, F, Cl, Br, I, COCH 3, CN, NO2, SO2CH3 were taken from the literature (calibration set). Substituent constants σm, σp, σI, σR, and σi for substituents N+(CH3)3, CH2N+(CH3)3, CH2Py +, CH2SO2CH3, and PO(OCH 3)2 were calculated by non-linear and PLS (partial least-square method with latent variables) calibration in three correlation models using the calibration set. Nonlinear regression appears more suitable and more universal than PLS calibration. The advantage of nonlinear regression is its independence on possibly missing data in the given solvent, evaluation of precision (standard deviation), the accessibility of necessary software, and easy calculation. However, in contrast to PLS calibration, this procedure fails in calculation of substituent constants with description of properties of substituents (substituent constants σI, σR). The obtained values of substituent constants are in good agreement with those published in the literature.

Design and synthesis of benzoic acid derivatives as influenza neuraminidase inhibitors using structure-based drug design

Chand, Pooran,Babu, Yarlagadda S.,Bantia, Shanta,Chu, Naiming,Cole, L. Brent,Kotian, Pravin L.,Laver, W. Graeme,Montgomery, John A.,Pathak, Ved P.,Petty, Sandra L.,Shrout, David P.,Walsh, David A.,Walsh, Gerald M.

, p. 4030 - 4052 (2007/10/03)

A series of 94 benzoic acid derivatives was synthesized and tested for its ability to inhibit influenza neuraminidase. The enzyme-inhibitor complex structure was determined by X-ray crystallographic analysis for compounds which inhibited the enzyme. The most potent compound tested in vitro, 5 (4- (acetylamino)-3-guanidinobenzoic acid), had an IC50 = 2.5 x 10-6 M against N9 neuraminidase. Compound 5 was oriented in the active site of the neuraminidase in a manner that was not predicted from the reported active site binding of GANA (4) with neuraminidase. In a mouse model of influenza, 5 did not protect the mice from weight loss due to the influenza virus when dosed intranasally.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 160446-22-0